Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Polymer from ethylenic monomers only
Patent
1983-11-28
1985-05-28
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Polymer from ethylenic monomers only
514161, A61K 3160, A61K 3174
Patent
active
045200092
ABSTRACT:
A constant release aspirin tablet comprising from 85-95 weight percent of aspirin, from 1.5-5 weight percent of microcrystalline cellulose, from 1-10 weight percent of cellulose acetate phthalate, from 0.75-4 weight percent of a plasticizer, from 0.75-5 weight percent of corn starch, and from 0.5 to 2 percent of a lubricant.
REFERENCES:
patent: 4375468 (1983-01-01), Dunn
Friedman Stanley J.
Verex Laboratories, Inc.
LandOfFree
Sustained released aspirin formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained released aspirin formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained released aspirin formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-868370